Back
Cerus Corp. 10K Form
Buy
56
CERS
Cerus Corp.
Last Price:
$2.06
Seasonality Move:
11.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | CERS/Cerus Corp. Quarterly |
| 2023-11-02 | 10Q | CERS/Cerus Corp. Quarterly |
| 2023-08-03 | 10Q | CERS/Cerus Corp. Quarterly |
| 2023-05-04 | 10Q | CERS/Cerus Corp. Quarterly |
| 2022-11-03 | 10Q | CERS/Cerus Corp. Quarterly |
| 2022-08-04 | 10Q | CERS/Cerus Corp. Quarterly |
Receive CERS News And Ratings
See the #1 stock for the next 7 days that we like better than CERS
CERS Financial Statistics
Sales & Book Value
| Annual Sales: | $180.3M |
|---|---|
| Cash Flow: | $94K |
| Price / Cash Flow: | 2328.54 |
| Annual Sales: | $0.32 |
| Price / Book: | 6.47 |
Profitability
| EPS (TTM): | -0.08470 |
|---|---|
| Net Income (TTM): | $-16M |
| Gross Margin: | $97.5M |
| Return on Equity: | -28.02% |
| Return on Assets: | -7.81% |
Cerus Corp. Earnings Forecast
Key Cerus Corp. Financial Ratios
-
The Gross Profit Margin over the past 28 years for CERS is 54.10%.
-
The Selling, General & Administrative Expenses for CERS have been equal to 42.10% of Gross Profit Margin.
-
The Research & Development expenses have been 31.57% of Revenue.
-
The Net Earning history of CERS is -11.63% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 17 years.
Cerus Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | CERS |
| CUSIP: | 157085 |
| Website: | cerus.com |
Debt
| Debt-to-Equity Ratio: | 1.6 |
|---|---|
| Current Ratio: | 1.89 |
| Quick Ratio: | 1.22 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CERS Technical Analysis vs Fundamental Analysis
Buy
56
Cerus Corp. (CERS)
is a Buy
Is Cerus Corp. a Buy or a Sell?
-
Cerus Corp. stock is rated a BuyThe current Cerus Corp. [CERS] share price is $2.07. The Score for CERS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.